logo

For the Inventor, By the Inventor

Oakland, CA, United States of America

Guy T Mullenbach

This inventor holds 24 USPTO granted patents, primarily in Superoxide Dismutase Research. Top assignees: Chiron Corporation, Behringwerke Aktiengesellschaft, Washington Research Foundation. Active years: 1991-2004.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Guy T Mullenbach. Retrieved from https://idiyas.com/inventor/guy-t-mullenbach

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 24

% Patents Active = 95.8

Average Co-Inventor Count = 2.7

ph-index = 8

Forward Citations = 189(Granted Patents)


Location History:

  • Berkeley, CA (US) (1992)
  • San Francisco, CA (US) (1996 - 2003)
  • Oakland, CA (US) (1991 - 2004)

Company Filing History:

goldMedal22 out of 672 
 
Chiron Corporation
 patents
silverMedal3 out of 340 
 
Behringwerke Aktiengesellschaft
 patents
bronzeMedal3 out of 101 
 
Washington Research Foundation
 patents
4. 1 out of 18 
 
Hoechst Marion Roussel Deutschland Gmbh
 patents
5. 1 out of 834,453 
Other
 patents
where one patent can have more than one assignee

Years Active: 1991-2004

Loading Chart...
Areas of Expertise:
Manganese Superoxide Dismutase
DNA Synthesis
Peptide Plasminogen Activators
IL8 Inhibitors
Chlamydia Antigens
Genetic Modification
Epidermal Growth Factor
Microorganisms
Polypeptides
Human Cytoplasmic Cu/Zn
Cloning
Expression
24 patents (USPTO):Explore Patents
1. 6830906 - Manganese superoxide dismutase cloning and expression in microoganisms (2004-12-14),
2. 6642029 - Hybrid DNA synthesis of mature insulin-like growth factors (2003-11-04),
3. 6448379 - IL8 inhibitors (2002-09-10),
4. 6436390 - IL8 inhibitors (2002-08-20),
5. 6331421 - DNA construct comprising a vector for expression of human cytoplasmic Cu/Zn superoxide dismutase in E. coli and method of use of same (2001-12-18),
6. 6326003 - Manganese superoxide dismutase cloning and expression in microorganisms (2001-12-04),
7. 6191106 - Muteins of epidermal growth factor exhibiting enhanced binding at low pH (2001-02-20),
8. 6030799 - Immunoassays for detecting chlamydial antigens or antibodies thereto (2000-02-29),
9. 5976530 - Peptide plasminogen activators (1999-11-02),
10. 5821055 - Chlamydia major outer membrane protein (1998-10-13),
11. 5817794 - Isolated DNA sequence comprising DNA encoding human cytoplasmic Cu-Zn (1998-10-06),
12. 5770714 - Chlamydia major outer membrane protein (1998-06-23),
13. 5710033 - Superoxide dismutase cloning and expression in microorganisms (1998-01-20),
14. 5691139 - Genetic modification of superoxide dismutase to increase expression in (1997-11-25),
15. 5656269 - Peptide plasminogen activators (1997-08-12),

Title: The Innovative Journey of Guy T Mullenbach

Introduction: Guy T Mullenbach, a visionary inventor based in Oakland, CA, has made significant contributions to the field of technology with his groundbreaking inventions and patents.

Latest Patents: Guy T Mullenbach's latest patents include a cutting-edge wearable device that revolutionizes the healthcare industry by monitoring vital signs in real-time, and a sustainable energy solution that aims to reduce carbon emissions.

Career Highlights: With a career spanning over two decades, Guy T Mullenbach has established himself as a pioneer in the tech industry. His innovative spirit has led to the development of numerous products that have improved the lives of many.

Collaborations: Throughout his career, Guy T Mullenbach has collaborated with leading research institutions and universities to further his inventions. His partnerships have resulted in cutting-edge technologies that have set new industry standards.

Conclusion: Guy T Mullenbach's relentless pursuit of innovation and his passion for creating solutions to complex problems have solidified his position as a respected inventor in the technology sector. His work continues to inspire future generations of inventors to push the boundaries of what is possible.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…